Literature DB >> 9566205

Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies.

E P Mamounas1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9566205

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  15 in total

Review 1.  Contribution of randomised controlled trials to understanding and management of early breast cancer.

Authors:  M Baum; J Houghton
Journal:  BMJ       Date:  1999-08-28

Review 2.  Recent developments in breast-conserving surgery for breast cancer patients.

Authors:  F Fitzal; O Riedl; R Jakesz
Journal:  Langenbecks Arch Surg       Date:  2008-09-10       Impact factor: 3.445

3.  Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.

Authors:  Ana María García Vicente; Ángel Soriano Castrejón; Alberto León Martín; Fernanda Relea Calatayud; María Del Mar Muñoz Sánchez; Miguel Ángel Cruz Mora; Germán Andrés Jiménez Londoño; Ruth Espinosa Aunión
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-18       Impact factor: 9.236

4.  A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study.

Authors:  Silvia Antolín; Ramón Mel; Manuel Ramos; Andrés García-Palomo; Concepción Almanza; Laura de Paz; Lourdes Calvo; Elena Alvarez; Ana González; Jesús García-Mata
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

5.  Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.

Authors:  Laura S Dominici; Viviana M Negron Gonzalez; Aman U Buzdar; Anthony Lucci; Elizabeth A Mittendorf; Huong T Le-Petross; Gildy V Babiera; Funda Meric-Bernstam; Kelly K Hunt; Henry M Kuerer
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

6.  Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).

Authors:  Judy C Boughey; Karla V Ballman; Linda M McCall; Elizabeth A Mittendorf; William Fraser Symmans; Thomas B Julian; David Byrd; Kelly K Hunt
Journal:  Ann Surg       Date:  2017-10       Impact factor: 12.969

7.  Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.

Authors:  H M Kuerer; A A Sahin; K K Hunt; L A Newman; T M Breslin; F C Ames; M I Ross; A U Buzdar; G N Hortobagyi; S E Singletary
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 8.  The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.

Authors:  D Lawrence Wickerham; Michael J O'Connell; Joseph P Costantino; Walter M Cronin; Soonmyung Paik; Charles E Geyer; Patricia A Ganz; Nicholas Petrelli; Eleftherios P Mamounas; Thomas B Julian; Norman Wolmark
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

Review 9.  Early operable breast cancer.

Authors:  A C Wolff; N E Davidson
Journal:  Curr Treat Options Oncol       Date:  2000-08

10.  Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.

Authors:  S Amat; P Bougnoux; F Penault-Llorca; F Fétissof; H Curé; F Kwiatkowski; J-L Achard; G Body; J Dauplat; P Chollet
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.